HomeO33 • FRA
add
Glycorex Transplantation AB (publ)
Previous close
€0.18
Day range
€0.18 - €0.18
Year range
€0.077 - €0.34
Avg Volume
106.00
P/E ratio
-
Dividend yield
-
Market news
NFLX
0.68%
0.29%
Financials
Income Statement
Revenue
Net income
(SEK) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 9.68M | 19.87% |
Operating expense | 9.86M | -3.60% |
Net income | -1.66M | 52.92% |
Net profit margin | -17.10 | 60.71% |
Earnings per share | — | — |
EBITDA | 868.00K | 182.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 14.48M | 29.69% |
Total assets | 56.30M | -9.17% |
Total liabilities | 15.72M | -26.81% |
Total equity | 40.58M | — |
Shares outstanding | 78.85M | — |
Price to book | 0.36 | — |
Return on assets | -6.98% | — |
Return on capital | -8.62% | — |
Cash Flow
Net change in cash
(SEK) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -1.66M | 52.92% |
Cash from operations | 1.44M | 2,419.35% |
Cash from investing | — | — |
Cash from financing | 6.38M | 344.29% |
Net change in cash | 7.74M | 388.63% |
Free cash flow | 660.62K | 658.25% |
About
CEO
Founded
1996
Website
Employees
20